Geode Capital Management’s Lexaria Bioscience LEXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $51.3K | Sell |
16,689
-5
| -0% | -$38 | ﹤0.01% | 4198 |
|
|
2026
Q2 | $140K | Sell |
16,694
-2,916
| -15% | -$31.6K | ﹤0.01% | 4026 |
|
|
2026
Q1 | $229K | Buy |
19,610
+4,962
| +34% | +$54K | ﹤0.01% | 3866 |
|
|
2025
Q4 | $136K | Buy |
14,648
+2,996
| +26% | +$42.5K | ﹤0.01% | 4023 |
|
|
2025
Q3 | $167K | Hold |
11,652
| – | – | ﹤0.01% | 3984 |
|
|
2025
Q2 | $152K | Buy |
11,652
+155
| +1% | +$2.67K | ﹤0.01% | 3955 |
|
|
2025
Q1 | $295K | Buy |
11,497
+385
| +3% | +$9.8K | ﹤0.01% | 3725 |
|
|
2024
Q4 | $350K | Buy |
11,112
+1,086
| +11% | +$40.1K | ﹤0.01% | 3710 |
|
|
2024
Q3 | $459K | Buy |
10,026
+2,374
| +31% | +$113K | ﹤0.01% | 3611 |
|
|
2024
Q2 | $319K | Buy |
7,652
+1,029
| +16% | +$46.3K | ﹤0.01% | 3739 |
|
|
2024
Q1 | $361K | Buy |
6,623
+3,050
| +85% | +$117K | ﹤0.01% | 3727 |
|
|
2023
Q4 | $67K | Buy |
3,573
+412
| +13% | +$7.96K | ﹤0.01% | 4282 |
|
|
2023
Q3 | $47K | Sell |
3,161
-95
| -3% | -$1.3K | ﹤0.01% | 4433 |
|
|
2023
Q2 | $35.3K | Hold |
3,256
| – | – | ﹤0.01% | 4577 |
|
|
2023
Q1 | $133K | Hold |
3,256
| – | – | ﹤0.01% | 4233 |
|
|
2022
Q4 | $119K | Sell |
3,256
-11
| -0.3% | -$395 | ﹤0.01% | 4330 |
|
|
2022
Q3 | $120K | Sell |
3,267
-61
| -2% | -$2.61K | ﹤0.01% | 4487 |
|
|
2022
Q2 | $148K | Buy |
3,328
+61
| +2% | +$2.45K | ﹤0.01% | 4419 |
|
|
2022
Q1 | $161K | Hold |
3,267
| – | – | ﹤0.01% | 4476 |
|
|
2021
Q4 | $198K | Hold |
3,267
| – | – | ﹤0.01% | 4472 |
|
|
2021
Q3 | $306K | Sell |
3,267
-92
| -3% | -$8.82K | ﹤0.01% | 4260 |
|
|
2021
Q2 | $352K | Buy |
+3,359
| New | +$300K | ﹤0.01% | 4095 |
|
Geode Capital Management's LEXX Position: Q3 2026 in Review
Geode Capital Management reduced its Lexaria Bioscience (LEXX) stake by 0.03% in Q3 2026, selling an estimated $38 and leaving 16,689 shares worth $51.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4198.
Geode Capital Management first reported a position in LEXX in Q2 2021 and has held it in 22 quarters since. The position peaked at $459K in Q3 2024. 1 fund tracked by Wall St. Rank holds LEXX as of Q3 2026.
- Geode Capital Management held 16,689 shares of Lexaria Bioscience worth $51.3K as of Q3 2026.
- Geode Capital Management sold 5 Lexaria Bioscience shares in Q3 2026, an estimated $38.
- Lexaria Bioscience made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #4198 holding.
- Geode Capital Management first reported a position in Lexaria Bioscience in Q2 2021 and has held it in 22 quarters since.
- Geode Capital Management's Lexaria Bioscience position peaked at $459K in Q3 2024.
- 1 fund tracked by Wall St. Rank held Lexaria Bioscience as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.